Postoperative Complications
Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
Subtype terms (28)
More specific conditions that are subtypes of Postoperative Complications in the MeSH hierarchy.
- Afferent Loop Syndrome
- Anastomotic Leak
22 drugs (19 approved, 3 experimental)
- Breast Cancer Lymphedema
3 drugs (2 approved, 1 experimental)
- Corneal Endothelial Cell Loss
14 drugs (8 approved, 6 experimental)
- Coronary-Subclavian Steal Syndrome
- Delayed Emergence from Anesthesia
28 drugs approved
- Emergence Delirium
36 drugs (32 approved, 4 experimental)
- Failed Back Surgery Syndrome
8 drugs (6 approved, 2 experimental)
- Graft Occlusion, Vascular
3 drugs experimental
- Incisional Hernia
7 drugs (5 approved, 2 experimental)
- Low Anterior Resection Syndrome
2 drugs experimental
- Malignant Hyperthermia
1 drug approved
- Postcholecystectomy Syndrome
1 drug experimental
- Postgastrectomy Syndromes
- Postoperative Cognitive Complications
32 drugs (29 approved, 3 experimental)
- Postoperative Hemorrhage
28 drugs (23 approved, 5 experimental)
- Postoperative Nausea and Vomiting
129 drugs (105 approved, 24 experimental)
- Postoperative Pain
273 drugs (169 approved, 104 experimental)
- Postpericardiotomy Syndrome
1 drug approved
- Prosthesis Failure
9 drugs (8 approved, 1 experimental)
- Prosthesis-Related Infections
33 drugs (26 approved, 7 experimental)
- Reperfusion Injury
88 drugs (71 approved, 17 experimental)
- Shock, Surgical
1 drug approved
- Short Bowel Syndrome
48 drugs (30 approved, 18 experimental)
- Slit Ventricle Syndrome
- Surgical Wound Dehiscence
3 drugs (2 approved, 1 experimental)
- Surgical Wound Infection
69 drugs (55 approved, 14 experimental)
- Vasoplegia
13 drugs (12 approved, 1 experimental)
Drugs by status
Approved for this indication (2)
Phase 4 trials (104)
- fluocinonide
- diclofenac
- melatonin
- ringer's lactate
- ferric derisomaltose
- propofol
- methylprednisolone
- angiotensin ii
- acetylcysteine
- urea
- procaine benzylpenicillin
- epoetin
- bisacodyl
- cefazolin
- ketamine
- cisatracurium
- clavulanate
- esmolol
- alpha-lipoic acid
- oxycodone
- ibuprofen
- suvorexant
- ferrous fumarate
- ferric carboxymaltose
- tamsulosin
- gabapentin
- Diatrizoate
- gelatin
- isoflurane
- sevoflurane
- +74 more
Phase 3 trials (49)
- metronidazole
- aminolevulinic acid
- human fibrin
- tobramycin
- bromfenac
- prednisone
- duloxetine
- dronedarone
- liraglutide
- l-glutamine
- granisetron
- warfarin
- icosapent ethyl
- epirubicin
- parecoxib
- mitomycin
- iodine
- landiolol
- nalbuphine
- phenazopyridine
- colchicine
- ranolazine
- tizanidine
- cyclophosphamide
- bevacizumab
- clonidine
- hydromorphone
- ulimorelin
- glucose
- vapreotidum
- +19 more
Phase 2 trials (31)
- levofloxacin
- daridorexant
- heparin
- desmopressin
- beetroot juice
- cn-105
- crofelemer
- da jian zhong tang
- diltiazem
- calcium hydroxide
- paclitaxel
- ino-1001
- lemborexant
- n-butyl-2-cyanoacrylate
- nitric oxide
- vitamin c
- pasireotide
- caffeine
- carboplatin
- acetylsalicylic acid
- omega-3 ethyl esters
- pentoxifylline
- autologous mesenchymal stem cells
- gentamicin
- celiprolol
- methenamine
- methylnaltrexone
- water
- grf6021
- sss17
- +1 more
Phase 1 trials (12)
Other trials (60)
- nitrous oxide
- mannitol
- ezetimibe
- phenylephrine
- sumatriptan
- edoxaban
- vitamin d3
- atracurium
- autologous blood
- dabigatran
- Bismuth Subcitrate Potassium
- cefixime
- norepinephrine
- docusate
- egg
- gemcitabine
- ginger
- lactulose
- fibrinogen (human)
- insulin human
- indocyanine green
- daptomycin
- ephedrine
- lavender
- mivacurium
- neem
- piperacillin
- platelet rich fibrin
- potassium citrate
- honey
- +30 more
Organizations
Organization Involved with Phase 4 Indications (59)
- Fresenius
- Merck
- Pfizer
- Vifor Inc.
- Region Syddanmark
- Huazhong University of Science and Technology
- Xuanwu Hospital
- Central South University
- Hebei University
- China Meitan General Hospital
- Eastern Hepatobiliary Surgery Hospital
- Guangxi Medical University
- Guangzhou Medical University
- Hospital General Universitario Gregorio Marañon
- Indiana University
- Medical University of Lodz
- Menoufia University
- Northwell Health
- Northwestern University
- Oregon Health and Science University
- Qinghai University
- Shaanxi Provincial People's Hospital
- Shanxi Medical University
- Sichuan University
- University of Pisa
- University of Athens
- Yuzuncu Yıl University
- Xinjiang Medical University
- Aalborg University
- Capital Medical University
- +29 more
Organization Involved with Phase 3 Indications (30)
- ISTA Pharmaceuticals
- Bausch & Lomb
- National Cancer Institute (NCI)
- Ataturk University
- Case Western Reserve University
- Duke University
- Federal University of Mato Grosso do Sul
- Gynecologic Oncology Group
- Instituto Mexicano del Seguro Social
- King Faisal University
- University of Saskatchewan
- University of Alberta
- University of Birmingham
- Mayo Clinic
- University of Cambridge
- Vanderbilt University
- University of Auckland
- Royal Marsden Hospital NHS Trust
- University of Missouri
- Orebro University
- University of Lyon
- University of Gothenburg
- Hopital Femme Mere Enfant
- Free University of Brussels
- University of Nantes
- University of Alabama, Birmingham
- Linkoping University
- Gynecologic Oncology of West Michigan
- Blekinge County Council Hospital
- Sage Products, Inc.
Organization Involved with Phase 2 Indications (11)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (56)
- STS Medical
- Ethicon
- Aarhus University
- University of Pittsburgh
- Cairo University
- Harvard University
- Faculdade de Ciências Médicas da Santa Casa de São Paulo
- Hospital Universitario Central de Asturias
- Malmö University
- Mansoura University
- Medical College of Wisconsin
- Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
- Tanta University
- Universidad Autonoma de Madrid
- Universidad Complutense de Madrid
- University of Milan
- University of Nottingham
- University of Parma
- University of Rochester
- University of South Carolina
- Utrecht University
- University of Valencia
- Fujian Medical University
- T.C. Ordu Universitesi
- Tel Aviv University
- Nanchang University
- Uppsala University
- Medical University of South Carolina
- University of Indonesia
- Universita' Cattolica del Sacro Cuore
- +26 more